日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials

HLA-B27状态是否影响伊克珠单抗治疗中轴型脊柱关节炎的疗效？来自COAST-V、COAST-W和COAST-X试验的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00810-5
Reveille, John D; Rudwaleit, Martin; Rahman, Proton; Maldonado-Cocco, Jose A; Magrey, Marina; Bolce, Rebecca; Ng, Khai Jing; Gibble, Theresa Hunter; Lisse, Jeffrey; Park, So Young; Kronbergs, Andris; Navarro-Compán, Victoria
关节炎
发表日期：2026
文献求助 收藏

Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials

伊克珠单抗与恶性肿瘤：25项随机临床试验数据的汇总分析

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2025.2056
Merola, Joseph F; Papp, Kim A; Deodhar, Atul; Blauvelt, Andrew; Kronbergs, Andris; Feely McDonald, Meghan; Eberhart, Nadezdha; Zhu, Danting; Inman, Elsa; Grace, Elsie; Holzkaemper, Thorsten; Rahman, Proton; Marzo-Ortega, Helena; Gottlieb, Alice B; Schwartzman, Sergio; Lebwohl, Mark
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events

伊克珠单抗治疗银屑病、银屑病关节炎或中轴型脊柱关节炎患者的长期安全性：脑心血管事件的事后分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01323-9
Lebwohl, Mark; Deodhar, Atul; Schwartzman, Sergio; Salvarani, Carlo; Feely McDonald, Meghan; Bello, Natalia; Grace, Elsie L; Inman, Elsa; Kronbergs, Andris; Ngantcha, Marcus; Rahman, Proton; Papp, Kim A; Merola, Joseph F; Gottlieb, Alice B; Blauvelt, Andrew
关节炎
银屑病
神经科学
发表日期：2025
文献求助 收藏

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

无论症状持续时间长短，伊克珠单抗都能改善中轴型脊柱关节炎患者的体征、症状和生活质量。

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03305-5
Navarro-Compán, Victoria; Reveille, John D; Rahman, Proton; Maldonado-Cocco, José A; Magrey, Marina; Bolce, Rebecca; Panni, Tommaso; Kronbergs, Andris; Rudwaleit, Martin
关节炎
发表日期：2025
文献求助 收藏

Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study

PRO-SPIRIT 研究对 14 种银屑病关节炎 (PsA) 药物和 5 类 PsA 治疗方案的早期疗效进行了比较：3 个月结果

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004318
Kristensen, Lars Erik; Ng, Khai Jing; Ngantcha, Marcus; Morel, Jacques; Lubrano, Ennio; Tillett, William; Alten, Rieke; Chandran, Vinod; Martinez Ferrer, Àngels; Zhu, Baojin; Kennedy, Dominika; Holzkämper, Thorsten; Gullick, Nicola; Kronbergs, Andris; Fakhouri, Walid; de la Torre, Inmaculada; McGonagle, Dennis G
关节炎
银屑病
发表日期：2024
文献求助 收藏

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

伊克珠单抗治疗成人银屑病、银屑病关节炎或中轴型脊柱关节炎的长期安全性：25项随机临床试验最终安全性数据的回顾性分析

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-023-03257-7
Deodhar, Atul; Blauvelt, Andrew; Lebwohl, Mark; Feely, Meghan; Kronbergs, Andris; Eberhart, Nadezhda; Zhu, Danting; Inman, Elsa; Grace, Elsie; Holzkaemper, Thorsten; Rahman, Proton; Marzo-Ortega, Helena; Papp, Kim A; Merola, Joseph F; Gottlieb, Alice B; Schwartzman, Sergio
关节炎
银屑病
发表日期：2024
文献求助 收藏

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results

ixekizumab治疗伴或不伴传统改善病情抗风湿药的活动性银屑病关节炎患者的疗效和安全性：SPIRIT-P1和SPIRIT-P2研究3年结果

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-022-06218-8
Coates, Laura C; Mease, Philip; Kronbergs, Andris; Helt, Cameron; Sandoval, David; Park, So Young; Combe, Bernard; Nash, Peter; Deodhar, Atul
关节炎
银屑病
发表日期：2022
文献求助 收藏

Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results

更正：ixekizumab治疗伴或不伴有传统改善病情抗风湿药物的活动性银屑病关节炎患者的疗效和安全性：SPIRIT-P1和SPIRIT-P2研究3年结果

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-022-06271-3
Coates, Laura C; Mease, Philip; Kronbergs, Andris; Helt, Cameron; Sandoval, David; Park, So Young; Combe, Bernard; Nash, Peter; Deodhar, Atul
关节炎
银屑病
发表日期：2022
文献求助 收藏

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies

伊克珠单抗（无论是否联合甲氨蝶呤）可改善银屑病关节炎的体征和症状：Spirit-P1 和 Spirit-P2 研究的第 52 周结果

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-020-02388-5
Combe, Bernard; Tsai, Tsen-Fang; Huffstutter, J Eugene; Sprabery, Aubrey Trevelin; Lin, Chen-Yen; Park, So Young; Kronbergs, Andris; Hufford, Matthew M; Nash, Peter
关节炎
银屑病
发表日期：2021
文献求助 收藏

Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials

更正：ixekizumab 在斑块状银屑病、银屑病关节炎和中轴型脊柱关节炎成人患者中的安全性：来自 21 项临床试验的数据

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keab566
Genovese, Mark C; Mysler, Eduardo; Tomita, Tetsuya; Papp, Kim A; Salvarani, Carlo; Schwartzman, Sergio; Gallo, Gaia; Patel, Himanshu; Lisse, Jeffrey R; Kronbergs, Andris; Leage, Soyi Liu; Adams, David H; Xu, Wen; Marzo-Ortega, Helena; Lebwohl, Mark G
银屑病
关节炎
发表日期：2021
文献求助 收藏